Skip to content

CARL - CARLSMED, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Carlsmed, Inc. Common Stock

CARL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CARLCarlsmed, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $17.19
52-wk low: $8.50
Prev close: $13.32
Mkt cap: $423.7M
P/S: 6.7x
P/B: 4.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$15.2M

MI
Millennium
Israel Englander · Q2 2026 13F
$3.1M
position
SC
Schonfeld
Steven Schonfeld · Q2 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -57.4%
Market cap: $424M

Valuation

P/S6.69
P/B4.82

Quality

Operating margin-58.3%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CARL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: HEALTH INFORMATION SERVICES
Market cap: $423.74M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

-57.4%

Op margin

-58.3%

ROE

-66.1%

$2.3M

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$1.1M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for CARL

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

Reports Aug 27, 2026, in 6 days

EPS expected

-$0.39

-$0.41 to -$0.36

Revenue expected

$19.2M

5 analysts

Last 30 days

1up0down

Analysts raising estimates

Estimate drift

+0.01

Change in 30 days

-66.1%

ROA-28.2%

Growth